Short-course antibiotic therapy in abdominal sepsis with source control: an integrative review

Authors

  • Christirobert Goncalves Neres Facultad de Ciencias Médicas, Universidad Privada del Este, filial Ciudad del Este, Paraguay Autor/a
  • Dillion Arpis Braz Ferreira Facultad de Ciencias Médicas, Universidad Privada del Este, filial Ciudad del Este, Paraguay Autor/a
  • Eduardo Silva de Araújo Facultad de Ciencias Médicas, Universidad Privada del Este, filial Ciudad del Este, Paraguay Autor/a
  • Lucília Maria de Oliveira Cardoso Facultad de Ciencias Médicas, Universidad Privada del Este, filial Ciudad del Este, Paraguay Autor/a https://orcid.org/0009-0002-8705-9795
  • Tainara Huane da Silva Terra Facultad de Ciencias Médicas, Universidad Privada del Este, filial Ciudad del Este, Paraguay Autor/a https://orcid.org/0009-0003-0839-5238
  • Maria Eduarda Mihok Facultad de Ciencias Médicas, Universidad Privada del Este, filial Ciudad del Este, Paraguay Autor/a https://orcid.org/0009-0000-5653-8887
  • Paola Britos Facultad de Ciencias Médicas, Universidad Privada del Este, filial Ciudad del Este, Paraguay; ChauxLab Institute, Asunción, Paraguay Autor/a https://orcid.org/0000-0002-5824-9867

DOI:

https://doi.org/10.5281/zenodo.21798798

Keywords:

abdominal sepsis, complicated intra-abdominal infection, short-course antibiotic therapy, source control, antibiotic treatment duration, mortality, antimicrobial resistance

Abstract

Background: Complicated intra-abdominal infection (cIAI) is a leading cause of sepsis in critical care, with variable mortality. Treatment relies on source control and systemic antibiotic therapy. Controversy over optimal duration has challenged prolonged courses (7–14 days) because of increased risk of adverse events, Clostridioides difficile infection and selection of microbial resistance. The STOP-IT trial was a milestone in demonstrating non-inferiority of a fixed four-day antibiotic course in cIAI with adequate source control. Objective: To synthesize evidence on short-course antibiotic therapy in abdominal sepsis with source control. Methods: Integrative review of clinical evidence on antibiotic duration in complicated intra-abdominal infection. Results: Short fixed courses after adequate source control are non-inferior to longer strategies for clinical outcomes in selected patients, with potential benefits regarding adverse events and antimicrobial resistance. Conclusions: After adequate source control, short antibiotic courses are a reasonable strategy in eligible patients; duration should be individualized according to clinical response and local ecology.

References

Napolitano LM. Intra-abdominal infections. Semin Respir Crit Care Med. 2022;43(1):10-27. doi:10.1055/s-0041-1741053

Ahmed S, Wilcox MH, Kirby A. Measuring outcomes in complicated intra-abdominal infections. Curr Opin Gastroenterol. 2020;36(1):1-4. doi:10.1097/mog.0000000000000591

Obst W, Esser T, Kaasch AJ, Geginat G, Meyer F, Croner RS, et al. The need of antimicrobial stewardship in post-operative infectious complications of abdominal surgery. Visc Med. 2022;38(5):345-53. doi:10.1159/000526785

Hellyer TP, Mantle T, McMullan R, Dark P. How to optimise duration of antibiotic treatment in patients with sepsis? BMJ. 2020;371:m4357. doi:10.1136/bmj.m4357

Sheppard D. Short-course antibiotic therapy: the next frontier in antimicrobial stewardship. Can Commun Dis Rep. 2022;48(11-12):496-501. doi:10.14745/ccdr.v48i1112a01

Ng-Kamstra JS, Soo A, McBeth P, Rotstein O, Zuege DJ, Gregson D, et al. STOP signs: a population-based interrupted time series analysis of antibiotic duration for complicated intra-abdominal infection before and after the publication of a landmark RCT. Ann Surg. 2023;277(5):e984-91. doi:10.1097/sla.0000000000005231

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71

Whittemore R, Knafl K. The integrative review: updated methodology. J Adv Nurs. 2005;52(5):546-53. doi:10.1111/j.1365-2648.2005.03621.x

Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. doi:10.1136/bmj.i4919

Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. doi:10.1136/bmj.l4898

Surat G, Meyer-Sautter P, Rüsch J, Braun-Feldweg J, Germer CT, Lock JF. Retrospective cohort analysis of the effect of antimicrobial stewardship on postoperative antibiotic therapy in complicated intra-abdominal infections: short-course therapy does not compromise patients' safety. Antibiotics (Basel). 2022;11(1):120. doi:10.3390/antibiotics11010120

Vinodhini P, Sureshkumar S, Gurushankari B, Mahalakshmy T, Kate V. Comparison of short-course and conventional antimicrobial duration in mild and moderate complicated intra-abdominal infections: a randomised controlled trial. Sultan Qaboos Univ Med J. 2023;23(2):212-9. doi:10.18295/squmj.1.2023.006

Ahmed S, Brown R, Pettinger R, Vargas-Palacios A, Burke D, Kirby A. The CABI trial: an unblinded parallel group randomised controlled feasibility trial of long-course antibiotic therapy (28 days) compared with short course (≤ 10 days) in the prevention of relapse in adults treated for complicated intra-abdominal infection. J Gastrointest Surg. 2021;25(4):1045-52. doi:10.1007/s11605-020-04545-2

Muñeton-López GA, Rodríguez LFC, Fandiño LCS, Lasso AD, Granados JPA, Salazar YID, et al. Effectiveness of five antibiotic regimens for the treatment of intra-abdominal infection in Bogotá. Surg Infect (Larchmt). 2022;23(10):933-9. doi:10.1089/sur.2022.296

Dulek A, O'Dell JC, Guidry CA. Prolonged therapy is not associated with delayed identification of recurrent intra-abdominal infection. Surg Infect (Larchmt). 2022;23(9):796-800. doi:10.1089/sur.2022.238

Published

2026-07-15

Issue

Section

Review Articles

How to Cite

Short-course antibiotic therapy in abdominal sepsis with source control: an integrative review. (2026). Revista UniNorte De Medicina Y Ciencias De La Salud, 15(2), 55–63. https://doi.org/10.5281/zenodo.21798798

Most read articles by the same author(s)

Similar Articles

1-10 of 269

You may also start an advanced similarity search for this article.